SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-313807
Filing Date
2020-12-09
Accepted
2020-12-09 16:04:32
Documents
18
Period of Report
2020-12-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d66456d8k.htm   iXBRL 8-K 32646
2 EX-1.1 d66456dex11.htm EX-1.1 207076
3 EX-5.1 d66456dex51.htm EX-5.1 7400
4 EX-99.1 d66456dex991.htm EX-99.1 10107
5 EX-99.2 d66456dex992.htm EX-99.2 10016
9 GRAPHIC g66456g1209131258054.jpg GRAPHIC 2536
10 GRAPHIC g66456g1209131345526.jpg GRAPHIC 2536
  Complete submission text file 0001193125-20-313807.txt   468523

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kura-20201208.xsd EX-101.SCH 3082
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20201208_lab.xml EX-101.LAB 18139
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20201208_pre.xml EX-101.PRE 11416
11 EXTRACTED XBRL INSTANCE DOCUMENT d66456d8k_htm.xml XML 3359
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 201377889
SIC: 2834 Pharmaceutical Preparations